Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis

Overview of attention for article published in Frontiers in immunology, January 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 9 X users
patent: 3 patents

video: 1 YouTube creator

Citations

dimensions_citation: 269 Dimensions

Readers on

mendeley: 294 Mendeley

Summary X Patents YouTube Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

TUMOR INFILTRATING LYMPHOCYTES AND ANTI-CD47 THERAPEUTICS

Application WO-2022130016-A1

World Intellectual Property Organisation (WIPO)

ANTI-CD47 ANTIBODIES AND METHODS OF USE

Application WO-2022063316-A1

World Intellectual Property Organisation (WIPO)

ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND POLYPEPTIDES BLOCKING…

Application WO-2021259902-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.